tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PTPI Stock Latest News

Petros to shift focus to development of tech as Rx-to-OTC switch solution
The FlyPetros to shift focus to development of tech as Rx-to-OTC switch solution
6d ago
PTPI
Petros Pharmaceuticals Amends President’s Employment Terms
PremiumCompany Announcements
Petros Pharmaceuticals Amends President’s Employment Terms
2M ago
8K
PTPI
Board Reshuffle at Petros Pharmaceuticals Following Resignations
PremiumCompany Announcements
Board Reshuffle at Petros Pharmaceuticals Following Resignations
3M ago
8K
PTPI
Petros executes initial test for app comprehension for STENDRA FDA pathway
PremiumThe Fly
Petros executes initial test for app comprehension for STENDRA FDA pathway
3M ago
PTPI
Petros Pharmaceuticals price target lowered to $1 from $4 at Maxim
PremiumThe Fly
Petros Pharmaceuticals price target lowered to $1 from $4 at Maxim
4M ago
PTPI
Petros announces results from analysis of STENDRA self-selection study
PremiumThe FlyPetros announces results from analysis of STENDRA self-selection study
5M ago
PTPI
Petros announces results from STENDRA pivotal consumer self-selection study
Premium
The Fly
Petros announces results from STENDRA pivotal consumer self-selection study
5M ago
PTPI
Petros Pharmaceuticals completes human factors study of AI-integrated web app
Premium
The Fly
Petros Pharmaceuticals completes human factors study of AI-integrated web app
7M ago
PTPI
Petros forms advisory committee to guide Rx-to-OTC switch for STENDRA
PremiumThe Fly
Petros forms advisory committee to guide Rx-to-OTC switch for STENDRA
7M ago
PTPI
Petros Pharmaceuticals launches U.S. distribution of STENDRA
PremiumThe Fly
Petros Pharmaceuticals launches U.S. distribution of STENDRA
7M ago
ME
PTPI
23andMe’s Lemonaid Health collabs with Petros Pharmaceuticals
PremiumThe Fly
23andMe’s Lemonaid Health collabs with Petros Pharmaceuticals
7M ago
ME
PTPI
Petros Pharmaceuticals files $100M mixed securities shelf
PremiumThe Fly
Petros Pharmaceuticals files $100M mixed securities shelf
8M ago
PTPI
Petros Pharmaceuticals expands online distribution for prescription STENDRA
PremiumThe FlyPetros Pharmaceuticals expands online distribution for prescription STENDRA
8M ago
ME
PTPI
Petros Pharmaceuticals expands online distribution for prescription STENDRA
Premium
The Fly
Petros Pharmaceuticals expands online distribution for prescription STENDRA
8M ago
ME
PTPI
Petros report ‘positive’ FDA feedback after informal technology component review
Premium
The Fly
Petros report ‘positive’ FDA feedback after informal technology component review
8M ago
PTPI
Petros Pharmaceuticals launches AI tool in collaboration with software provider
PremiumThe Fly
Petros Pharmaceuticals launches AI tool in collaboration with software provider
9M ago
PTPI
Petros Pharmaceuticals enters AI-licensing agreement with software provider
PremiumThe Fly
Petros Pharmaceuticals enters AI-licensing agreement with software provider
10M ago
PTPI
Petros Pharmaceuticals announces two upcoming FDA meetings on STENDRA
PremiumThe Fly
Petros Pharmaceuticals announces two upcoming FDA meetings on STENDRA
11M ago
PTPI
Petros completes initial cohort of Phase 2 equivalent SSS for STENDRA
PremiumThe Fly
Petros completes initial cohort of Phase 2 equivalent SSS for STENDRA
11M ago
PTPI
Petros Pharmaceuticals completes Human Factors Study for STENDRA
PremiumThe FlyPetros Pharmaceuticals completes Human Factors Study for STENDRA
1y ago
PTPI
Petros Pharmaceuticals initiated with bullish view at Maxim
Premium
The Fly
Petros Pharmaceuticals initiated with bullish view at Maxim
1y ago
PTPI
Petros Pharmaceuticals partners with Idea Evolver
Premium
The Fly
Petros Pharmaceuticals partners with Idea Evolver
1y ago
PTPI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >